Abstract
Introduction Building on past frameworks, our aim was to systematically analyze the healthcare access and quality (HAQ) index for surgically treatable conditions, its progress over time, and the gap compared to non-surgical HAQ across 204 countries and territories from 1990 to 2019.
Methods Data was obtained from the Global Burden of Disease 2019 study. Of the 32 conditions with preventable mortality included in the HAQ index, 14 were considered surgically treatable following an existing framework. We used mortality-to-incidence ratios and risk-standardized death rates. An easily interpretable, computable, and partially compensatory composite index ranging from 0 (worst) to 100 (best) was constructed using the adjusted Mazziotta Pareto index methodology. The indicators were scaled by min-max scaling, aggregated using arithmetic mean, and the aggregate was penalized for imbalance using a variance term. Similarly, a non-surgical HAQ index was calculated, including the 18 remaining conditions. To track progress over time, relative change was calculated as the ratio of surgical HAQ in 2019 to that in 1990. Further, the relative gap in 2019 was calculated as the surgical-to-non-surgical HAQ ratio. Ratio values >1 depicted improvement over time or better performing surgical systems.
Results In 2019, surgical HAQ varied from 18.00 for the Central African Republic to 98.25 for Canada. The surgical HAQ showed the greatest relative change for Ethiopia (2019:1990 ratio=3.88), while Zimbabwe saw a slight worsening (ratio=0.92). In 2019, Mauritius had the largest surgical-to-non-surgical HAQ ratio of 1.16, while the surgical HAQ lagged behind its non-surgical HAQ for the Central African Republic (ratio=0.44).
Conclusion The presented index and comprehensive global analysis are valuable for global assessments, policymaking, and advocacy for investing in surgical systems.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
